Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 11, 2026

High Throughput Microfluidic Rapid and Low Cost Prototyping Packaging Methods
07:51

High Throughput Microfluidic Rapid and Low Cost Prototyping Packaging Methods

Published on: December 23, 2013

Microfluidic approach for fast labeling optimization and dose-on-demand implementation.

Giancarlo Pascali1, Grazia Mazzone, Giuseppe Saccomanni

  • 1Radiopharmacy Department, Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy. pascali@ifc.cnr.it

Nuclear Medicine and Biology
|July 9, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Discovery, Mechanism, and Application: An Integrated Strategy for Bioactive Natural Products.

Molecules (Basel, Switzerland)·2026
Same author

Next-Gen <sup>18</sup>F-Relay Reagent: Optimising [<sup>18</sup>F]Ethanesulfonyl Fluoride.

International journal of molecular sciences·2026
Same author

In Vitro Evaluation of Virucidal Effect of Polysaccharides Extracted and Purified from <i>Arthrospira platensis</i> and <i>Dunaliella salina</i> on Human Adenovirus Type 5 in A549 Cells.

Molecules (Basel, Switzerland)·2026
Same author

Protective Effects on Keratinocytes by Extracts Enriched in Polysaccharides from <i>Limnospira platensis</i> Grown Under Autotrophic and Mixotrophic Conditions.

Nutrients·2026
Same author

Sulfated Polysaccharide-Rich Fractions from Spirulina Platensis (SPPs) Exert Multi-Target Anticancer Activity in Non-Small Cell Lung Cancer (NSCLC) Cells.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Development and characterisation of novel oxytocin analogues for PET imaging.

Communications chemistry·2025
Same journal

Preparation of electroplated zinc-68 targets for gallium-68 cyclotron production using recovered zinc-68.

Nuclear medicine and biology·2026
Same journal

Enhanced pre-therapy dosimetry for SSTR PET: A head-to-head preclinical assessment of [<sup>89</sup>Zr]Zr-DFO-TOC and [<sup>89</sup>Zr]Zr-DFO-TATE.

Nuclear medicine and biology·2026
Same journal

Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs.

Nuclear medicine and biology·2026
Same journal

Comparative intra-articular retention of [<sup>177</sup>Lu]Lu-MAA and <sup>90</sup>Y resin in a rat knee model.

Nuclear medicine and biology·2026
Same journal

Evaluating the tumour detection efficacy of [<sup>18</sup>F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model.

Nuclear medicine and biology·2026
Same journal

Development of a pyrogallol-formaldehyde resin column for one-step pre-purification of <sup>68</sup>Ge/<sup>68</sup>Ga generator eluates: Enhanced [<sup>68</sup>Ga]Ga-DOTA-TATE radiolabeling yield by selective removal of tetravalent cationic impurities.

Nuclear medicine and biology·2026
See all related articles

This study introduces a microfluidic system for rapid radiotracer development. The platform enables on-demand production of novel positron emission tomography (PET) imaging agents, like the CB2 ligand CB41, with high yields and short reaction times.

Area of Science:

  • Radiochemistry
  • Molecular Imaging
  • Microfluidics

Background:

  • Positron emission tomography (PET) requires novel radiotracers for diagnostics and research.
  • Microfluidic technology offers enhanced radiochemical productivity, reducing time, precursor use, and enabling flexible experimental design.

Purpose of the Study:

  • To develop and validate a microfluidic system for efficient fluorine-18 radiolabeling.
  • To demonstrate sequential, on-demand production of radiotracers using a single batch of fluoride-18.

Main Methods:

  • Utilized a microfluidic platform for sequential fluorine-18 labeling reactions on multiple substrates.
  • Integrated solid-phase extraction (SPE) for repeatable radiotracer purification.
  • Optimized reaction conditions (temperature, flow rate, reactant ratios) for labeling various precursors.

More Related Videos

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Related Experiment Videos

Last Updated: Jun 11, 2026

High Throughput Microfluidic Rapid and Low Cost Prototyping Packaging Methods
07:51

High Throughput Microfluidic Rapid and Low Cost Prototyping Packaging Methods

Published on: December 23, 2013

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Main Results:

  • Achieved rapid optimization of labeling conditions for ethyl/propyl ditosylate and a novel CB2 receptor agonist (CB41).
  • Obtained high incorporation yields (60-85%) in short reaction times (<90 seconds).
  • Successfully prepared sequential, injectable doses of CB41 for small animal PET imaging.

Conclusions:

  • Microfluidic systems facilitate rapid optimization of radiolabeling parameters for diverse precursors.
  • Demonstrated proof-of-principle for dose-on-demand radiotracer production using microfluidics.
  • This approach accelerates the development of new PET imaging agents.